Opthea Limited (OPT.AX)
AUD 0.66
(1.54%)
AUD 0.66
(1.54%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 191.96 Million USD | -14.09% |
| 2023 | 223.45 Million USD | 67.65% |
| 2022 | 133.28 Million USD | 150.88% |
| 2021 | 53.12 Million USD | 114.97% |
| 2020 | 24.71 Million AUD | -31.85% |
| 2019 | 36.26 Million AUD | 21.37% |
| 2018 | 29.88 Million AUD | 202.76% |
| 2017 | 9.86 Million AUD | 22.54% |
| 2016 | 8.05 Million AUD | 18.4% |
| 2015 | 6.8 Million AUD | 3.2% |
| 2014 | 6.59 Million AUD | -4.14% |
| 2013 | 6.87 Million AUD | -22.72% |
| 2012 | 8.89 Million AUD | -27.5% |
| 2011 | 12.27 Million AUD | 41.45% |
| 2010 | 8.67 Million AUD | 2.56% |
| 2009 | 8.46 Million AUD | 2.38% |
| 2008 | 8.26 Million AUD | -42.53% |
| 2007 | 14.37 Million AUD | 305.57% |
| 2006 | 3.54 Million AUD | 52.63% |
| 2005 | 2.32 Million AUD | 29.32% |
| 2004 | 1.79 Million AUD | -38.94% |
| 2003 | 2.94 Million AUD | 122.43% |
| 2002 | 1.32 Million AUD | 10266.75% |
| 2001 | 12.75 Thousand AUD | -97.55% |
| 2000 | 520.09 Thousand AUD | -96.51% |
| 1999 | 14.88 Million AUD | 113428.44% |
| 1998 | 13.11 Thousand AUD | 93.32% |
| 1997 | 6783.17 AUD | -96.75% |
| 1996 | 208.68 Thousand AUD | 53.84% |
| 1995 | 135.64 Thousand AUD | 18.24% |
| 1994 | 114.71 Thousand AUD | 53.34% |
| 1993 | 74.81 Thousand AUD | 69.76% |
| 1992 | 44.07 Thousand AUD | -35.43% |
| 1991 | 68.25 Thousand AUD | 760.49% |
| 1990 | 7931.98 AUD | 205.06% |
| 1989 | -7550.02 AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 143.89 Million USD | 0.0% |
| 2024 FY | 191.96 Million USD | -14.09% |
| 2023 FY | 223.45 Million USD | 67.65% |
| 2023 Q2 | 117.95 Million USD | 0.0% |
| 2023 Q4 | 105.63 Million USD | 0.0% |
| 2022 Q2 | 53.99 Million USD | 0.0% |
| 2022 Q4 | 84.76 Million USD | 0.0% |
| 2022 FY | 133.28 Million USD | 150.88% |
| 2021 FY | 53.12 Million USD | 114.97% |
| 2021 Q2 | 26.41 Million USD | 0.0% |
| 2020 Q4 | 13.17 Million AUD | 0.0% |
| 2020 FY | 24.71 Million AUD | -31.85% |
| 2020 Q2 | 11.53 Million AUD | 0.0% |
| 2019 Q2 | 19.79 Million AUD | 0.0% |
| 2019 Q4 | 17.11 Million AUD | 0.0% |
| 2019 FY | 36.26 Million AUD | 21.37% |
| 2018 Q4 | 16.47 Million AUD | 0.0% |
| 2018 FY | 29.88 Million AUD | 202.76% |
| 2017 FY | 9.86 Million AUD | 22.54% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 FY | 8.05 Million AUD | 18.4% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | 6.8 Million AUD | 3.2% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | 6.59 Million AUD | -4.14% |
| 2013 Q1 | 667.63 Thousand AUD | 0.0% |
| 2013 Q3 | 496.56 Thousand AUD | 0.0% |
| 2013 Q2 | 496.56 Thousand AUD | -25.62% |
| 2013 FY | 6.87 Million AUD | -22.72% |
| 2013 Q4 | - AUD | -100.0% |
| 2012 Q2 | 667.63 Thousand AUD | 27.55% |
| 2012 FY | 8.89 Million AUD | -27.5% |
| 2012 Q1 | 523.41 Thousand AUD | 0.0% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 Q3 | 667.63 Thousand AUD | 0.0% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 FY | 12.27 Million AUD | 41.45% |
| 2011 Q3 | 523.41 Thousand AUD | 0.0% |
| 2011 Q2 | 523.41 Thousand AUD | 80.32% |
| 2011 Q1 | 290.27 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 290.27 Thousand AUD | 0.0% |
| 2010 Q1 | 513.32 Thousand AUD | 0.0% |
| 2010 Q2 | 290.27 Thousand AUD | -43.45% |
| 2010 FY | 8.67 Million AUD | 2.56% |
| 2009 Q4 | - AUD | -100.0% |
| 2009 FY | 8.46 Million AUD | 2.38% |
| 2009 Q3 | 513.32 Thousand AUD | 0.0% |
| 2009 Q2 | 513.32 Thousand AUD | 5.21% |
| 2009 Q1 | 487.89 Thousand AUD | 0.0% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 Q3 | 487.89 Thousand AUD | 0.0% |
| 2008 Q2 | 487.89 Thousand AUD | -80.36% |
| 2008 Q1 | 2.48 Million AUD | 0.0% |
| 2008 FY | 8.26 Million AUD | -42.53% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 FY | 14.37 Million AUD | 305.57% |
| 2007 Q1 | 102.54 Thousand AUD | 0.0% |
| 2007 Q2 | 2.48 Million AUD | 2322.76% |
| 2007 Q3 | 2.48 Million AUD | 0.0% |
| 2006 Q3 | 102.54 Thousand AUD | 0.0% |
| 2006 FY | 3.54 Million AUD | 52.63% |
| 2006 Q1 | 38.18 Thousand AUD | 0.0% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q2 | 102.54 Thousand AUD | 168.52% |
| 2005 FY | 2.32 Million AUD | 29.32% |
| 2005 Q1 | 37.46 Thousand AUD | 0.0% |
| 2005 Q2 | 38.18 Thousand AUD | 1.93% |
| 2005 Q3 | 38.18 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2004 Q3 | 37.46 Thousand AUD | 0.0% |
| 2004 FY | 1.79 Million AUD | -38.94% |
| 2004 Q4 | - AUD | -100.0% |
| 2004 Q2 | 37.46 Thousand AUD | -93.44% |
| 2004 Q1 | 571.14 Thousand AUD | 0.0% |
| 2003 Q2 | 571.14 Thousand AUD | -62.46% |
| 2003 Q3 | 571.14 Thousand AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 FY | 2.94 Million AUD | 122.43% |
| 2003 Q1 | 1.52 Million AUD | 0.0% |
| 2002 Q2 | 1.52 Million AUD | 7056.26% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 Q3 | 1.52 Million AUD | 0.0% |
| 2002 FY | 1.32 Million AUD | 10266.75% |
| 2002 Q1 | 21.25 Thousand AUD | 0.0% |
| 2001 FY | 12.75 Thousand AUD | -97.55% |
| 2001 Q2 | 21.25 Thousand AUD | -96.52% |
| 2001 Q1 | 611.68 Thousand AUD | 0.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2001 Q3 | 21.25 Thousand AUD | 0.0% |
| 2000 Q2 | 611.68 Thousand AUD | -48.39% |
| 2000 Q1 | 1.18 Million AUD | 0.0% |
| 2000 FY | 520.09 Thousand AUD | -96.51% |
| 2000 Q4 | - AUD | -100.0% |
| 2000 Q3 | 611.68 Thousand AUD | 0.0% |
| 1999 Q4 | - AUD | -100.0% |
| 1999 FY | 14.88 Million AUD | 113428.44% |
| 1999 Q3 | 1.18 Million AUD | 0.0% |
| 1999 Q2 | 1.18 Million AUD | 339.3% |
| 1999 Q1 | -495.25 Thousand AUD | 0.0% |
| 1998 Q1 | -429.31 Thousand AUD | 0.0% |
| 1998 Q2 | -495.25 Thousand AUD | -15.36% |
| 1998 Q4 | -495.25 Thousand AUD | 0.0% |
| 1998 Q3 | -495.25 Thousand AUD | 0.0% |
| 1998 FY | 13.11 Thousand AUD | 93.32% |
| 1997 FY | 6783.17 AUD | -96.75% |
| 1997 Q4 | - AUD | 100.0% |
| 1997 Q2 | -429.31 Thousand AUD | -57.84% |
| 1997 Q3 | -429.31 Thousand AUD | 0.0% |
| 1997 Q1 | -272 Thousand AUD | 0.0% |
| 1996 Q2 | -272 Thousand AUD | -64.1% |
| 1996 Q4 | -272 Thousand AUD | 0.0% |
| 1996 FY | 208.68 Thousand AUD | 53.84% |
| 1996 Q1 | -165.75 Thousand AUD | 0.0% |
| 1996 Q3 | -272 Thousand AUD | 0.0% |
| 1995 FY | 135.64 Thousand AUD | 18.24% |
| 1995 Q3 | -165.75 Thousand AUD | 0.0% |
| 1995 Q4 | -165.75 Thousand AUD | 0.0% |
| 1995 Q2 | -165.75 Thousand AUD | -1005.0% |
| 1995 Q1 | -15 Thousand AUD | 0.0% |
| 1994 Q2 | -15 Thousand AUD | 88.24% |
| 1994 FY | 114.71 Thousand AUD | 53.34% |
| 1994 Q1 | -127.5 Thousand AUD | 0.0% |
| 1994 Q3 | -15 Thousand AUD | 0.0% |
| 1994 Q4 | -15 Thousand AUD | 0.0% |
| 1993 Q2 | -127.5 Thousand AUD | -553.85% |
| 1993 Q1 | -19.5 Thousand AUD | 0.0% |
| 1993 FY | 74.81 Thousand AUD | 69.76% |
| 1993 Q4 | -127.5 Thousand AUD | 0.0% |
| 1993 Q3 | -127.5 Thousand AUD | 0.0% |
| 1992 Q2 | -19.5 Thousand AUD | 55.17% |
| 1992 Q4 | -19.5 Thousand AUD | 0.0% |
| 1992 FY | 44.07 Thousand AUD | -35.43% |
| 1992 Q1 | -43.5 Thousand AUD | 0.0% |
| 1992 Q3 | -19.5 Thousand AUD | 0.0% |
| 1991 Q3 | -43.5 Thousand AUD | 0.0% |
| 1991 FY | 68.25 Thousand AUD | 760.49% |
| 1991 Q1 | -154 Thousand AUD | 0.0% |
| 1991 Q2 | -43.5 Thousand AUD | 71.75% |
| 1991 Q4 | -43.5 Thousand AUD | 0.0% |
| 1990 FY | 7931.98 AUD | 205.06% |
| 1990 Q1 | -133.5 Thousand AUD | 0.0% |
| 1990 Q3 | -154 Thousand AUD | 0.0% |
| 1990 Q2 | -154 Thousand AUD | -15.36% |
| 1990 Q4 | -154 Thousand AUD | 0.0% |
| 1989 Q4 | -133.5 Thousand AUD | 0.0% |
| 1989 FY | -7550.02 AUD | 0.0% |
| 1989 Q2 | -133.5 Thousand AUD | 0.0% |
| 1989 Q3 | -133.5 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 39.57 Million AUD | -385.08% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -26929.401% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -3127.149% |
| Biome Australia Limited | 7.91 Million AUD | -2326.52% |
| Patrys Limited | 4.93 Million AUD | -3791.247% |
| Orthocell Limited | 15.36 Million AUD | -1149.012% |
| Imugene Limited | 135.09 Million AUD | -42.102% |
| Noxopharm Limited | 7 Million AUD | -2642.317% |
| PYC Therapeutics Limited | 60.91 Million AUD | -215.132% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | -871.134% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -1661.366% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -21417.559% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -1625.772% |
| CSL Limited | 7.56 Billion AUD | 97.461% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -1679.902% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -6852.786% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | -513.373% |
| Starpharma Holdings Limited | 22.81 Million AUD | -741.372% |
| Nanollose Limited | 12.5 Thousand AUD | -1535516.343% |
| Memphasys Limited | 3.67 Million AUD | -5118.8% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -5637.421% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -9668.235% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -2175.648% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -31797.81% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -4553.354% |
| Race Oncology Limited | 14.77 Million AUD | -1199.67% |
| Nyrada Inc. | 4.55 Million AUD | -4114.277% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 28.707% |
| Dimerix Limited | 25.64 Million AUD | -648.607% |
| PharmAust Limited | 6.65 Million AUD | -2783.697% |
| Immutep Limited | 42.87 Million AUD | -347.735% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | -240.928% |
| Alterity Therapeutics Limited | 23.4 Million AUD | -720.139% |
| BTC Health Limited | -1.03 Million AUD | 18577.468% |
| Acrux Limited | 8.55 Million AUD | -2145.233% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | -487.11% |
| Biotron Limited | 5.11 Million AUD | -3656.204% |
| Tissue Repair Ltd | 6.66 Million AUD | -2779.449% |
| AdAlta Limited | 6.76 Million AUD | -2735.766% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -64054.223% |
| Hexima Limited | 1 Million AUD | -18930.225% |
| AnteoTech Limited | 12.18 Million AUD | -1475.182% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | -194.866% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | -785.276% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -4123.339% |
| Actinogen Medical Limited | 22.77 Million AUD | -743.053% |
| Immuron Limited | 9.13 Million AUD | -2000.779% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -2221.491% |